[EN] AMINOPYRIMIDINONES AS INTERLEUKIN RECEPTOR-ASSOCIATED KINASE INHIBITORS<br/>[FR] AMINOPYRIMIDINONES EN TANT QU'INHIBITEURS DE KINASES ASSOCIÉES AU RÉCEPTEUR DE L'INTERLEUKINE
申请人:MERCK SHARP & DOHME
公开号:WO2013066729A1
公开(公告)日:2013-05-10
This invention relates to aminopyrimidinone compounds of Formula (I) that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment or prevention of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease.
Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines
作者:Rita L. Civiello、Xiaojun Han、Brett R. Beno、Prasad V. Chaturvedula、John J. Herbst、Cen Xu、Charles M. Conway、John E. Macor、Gene M. Dubowchik
DOI:10.1016/j.bmcl.2016.01.026
日期:2016.2
improved oral bioavailability, metabolic stability, and pharmacokinetic properties, lower molecular weight, structurallysimpler piperidine and piperazine analogs of BMS-694153 were prepared. Several were found to have nM binding affinity in vitro. The synthesis and SAR of these substituted piperidine and piperazine CGRP antagonists are discussed.